Medical information Clinical review pending

Diagnostic Testing

Chlamydia Qualitative PCR

Detects Chlamydia trachomatis, a common STI, using a highly sensitive PCR test. Essential for sexually active individuals or those with symptoms. Home sample collection available.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Urine sample, endocervical swab, urethral swab, eye swab, or semen sample. Confirm with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: Follow specific instructions provided by the laboratory or your doctor regarding sample collection. For urine samples, the first-catch urine is often preferred. Avoid sexual activity for 24 hours before the test if possible. Confirm with the laboratory before booking.

Test priceKSh 10,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chlamydia Qualitative PCR test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Symptoms of Chlamydia (e.g., unusual discharge, burning urination, pelvic pain).
✓Sexually active individuals, especially with multiple partners.
✓Screening for individuals at risk.
✓Women planning pregnancy or currently pregnant.
✓Individuals with a history of STIs.
✓Partner notification following a positive diagnosis.

In plain language

What this test helps you understand

This test is used to diagnose Chlamydia trachomatis infection, a common sexually transmitted infection. Early diagnosis allows for prompt treatment, reducing the risk of complications like pelvic inflammatory disease, infertility, and ectopic pregnancy. It is also important for screening individuals at risk.

The Chlamydia Qualitative PCR test is a vital diagnostic procedure designed to detect the presence of the bacterium Chlamydia trachomatis, which is responsible for one of the most common sexually transmitted infections (STIs) globally. This test is crucial for early detection and treatment, helping to prevent complications such as infertility and chronic pelvic pain. This test utilizes the End Point PCR method, a highly sensitive technique that amplifies the DNA of Chlamydia trachomatis from various sample types, including urine, eye, endocervical and urethral swabs, and semen. By detecting the genetic material of the bacterium, the test provides accurate results, confirming the presence or absence of the infection.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationFollow specific instructions provided by the laboratory or your doctor regarding sample collection. For urine samples, the first-catch urine is often preferred. Avoid sexual activity for 24 hours before the test if possible. Confirm with the laboratory before booking.

SampleUrine sample, endocervical swab, urethral swab, eye swab, or semen sample. Confirm with the laboratory before booking.

MethodologyEnd Point Polymerase Chain Reaction (PCR).

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects the presence of Chlamydia trachomatis DNA but cannot distinguish between active and past infection. A positive result requires clinical correlation and may necessitate further testing or treatment. False negatives can occur if the sample is collected improperly or if the bacterial load is very low. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Chlamydia is a common sexually transmitted infection (STI) caused by the bacterium Chlamydia trachomatis. It often has no symptoms but can lead to serious health problems if left untreated.

Early detection allows for timely treatment, which prevents complications like pelvic inflammatory disease, infertility, and ectopic pregnancy. It also helps prevent spreading the infection to others.

Yes, all testing and results are kept confidential. We offer discreet services, including home sample collection, to ensure your privacy.

If your result is positive, your doctor will discuss treatment options with you. If negative, discuss with your doctor about future screening needs based on your risk factors.

The Chlamydia Qualitative PCR test can be conducted with a Doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or for individuals planning to travel abroad.

Yes, we offer a convenient home sample collection service across Kenya. Please contact us to arrange this.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp